Added to YB: 2025-02-07
Pitch date: 2025-02-07
EVO [bullish]
Evotec SE
-33.55%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
Market Cap
EUR 1.5B
Pitch Price
EUR 4.53
Price Target
N/A
Dividend
N/A
EV/EBITDA
65.10
P/E
-9.02
EV/Sales
2.21
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
Evotec SE: A Pioneering AI-Driven CDMO with Takeover Potential
EVO/EVT: Vertically integrated CDMO spanning drug discovery to biologics manufacturing. Positioned for AI-powered drug discovery with PanOmics/PanHunter. 140 co-owned drug pipeline, biologics mfg +75% YoY. New leadership driving efficiency. Trades 2x rev. Takeover potential (rejected €12/share offer). Biotech cycle near bottom.
Read full article (1 min)